allumbra

Pre-Seed
allumbra.com Biotech & Healthcare Broomfield, United States
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced Mar 9, 2026
Investors Undisclosed
Decision Makers Profile Active

About allumbra

allumbra is a blood test that catches head and neck cancer recurrence in most patients for whom circulating DNA tests do not work.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Broomfield, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website allumbra.com
Domain Registered Date Jan 16, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Pre-Seed announced

  2. Milestone

    Website domain registered

    allumbra.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for allumbra.

Funding History

1 Round
Pre-Seed equity · Mar 9, 2026
Undisclosed

Founders & Leadership

1

Maria Navas-Moreno

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts